AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Eriglim M 4mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Simpatico Healthcare

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Eriglim M 4mg/500mg Tablet SR

Diabetac Duo 4mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-drug formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Diabetac Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect. Learn to identify its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular mealtimes and carry readily available glucose sources like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabetac Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment; its suitability may be affected. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Eriglim M 4mg/500mg Tablet SR

No information provided. A rephrased version cannot be created.

Uses of Eriglim M 4mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Eriglim M 4mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Administer Eriglim M 4mg/500mg Tablet SR with a meal.

Common Side effects of Eriglim M 4mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Eriglim M 4mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Eriglim M 4mg/500mg Extended-Release Tablet with a meal.

How Eriglim M 4mg/500mg Tablet SR works:

Eriglim M 4mg/500mg extended-release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eriglim M 4mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Eriglim M 4mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Eriglim M 4mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Eriglim M 4mg/500mg SR tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment with Eriglim M 4mg/500mg SR tablets.

LiverLiverCAUTION

Patients with liver impairment should use Eriglim M 4mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiation with a low dose is standard practice; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Eriglim M 4mg/500mg Tablet SR :

Should you forget a dose of Eriglim M 4mg/500mg SR Tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Eriglim M 4mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Eriglim M 4mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Eriglim M 4mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Eriglim M 4mg/500mg Tablet SR and seek immediate medical attention.
Eriglim M 4mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Eriglim M 4mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Eriglim M 4mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Eriglim M 4mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Eriglim M 4mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Eriglim M 4mg/500mg Table...
91
MRP 105
13% off